3-Methylbenzylpiperazine

3-Methylbenzylpiperazine (3-Me-BZP) is a stimulant drug which is a derivative of benzylpiperazine. It has been sold as a designer drug, first being identified in Sweden in February 2012.[1]

3-Methylbenzylpiperazine
Identifiers
IUPAC name
  • 1-(3-methylbenzyl)piperazine
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.023.805
Chemical and physical data
FormulaC12H18N2
Molar mass190.290 g·mol−1
3D model (JSmol)
SMILES
  • CC1=CC(=CC=C1)CN2CCNCC2
InChI
  • InChI=1S/C12H18N2/c1-11-3-2-4-12(9-11)10-14-7-5-13-6-8-14/h2-4,9,13H,5-8,10H2,1H3
  • Key:VTEOTZPEMDQENX-UHFFFAOYSA-N

See also

References
  1. "EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)" (PDF). Lisbon: EMCDDA. May 2013. {{cite journal}}: Cite journal requires |journal= (help)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.